Combination Products
Combination products demand coordinated expertise across drugs, biologics, medical devices, manufacturing, and regulatory affairs. GSAP brings these disciplines together to help organizations reduce complexity, align development activities, and navigate global regulatory pathways from concept through commercialization.

How We Support Combination Product Companies
- Regulatory Strategy & Product Classification
PMOA assessment, product classification, FDA Request for Designation (RFD) support, Office of Combination Products interactions, global regulatory pathway assessments, and regulatory gap analyses. - Quality Systems & Regulatory Compliance
FDA 21 CFR Part 4 compliance, integration of drug and device quality system requirements, quality system implementation, and global regulatory gap assessments. - Risk Management & Validation
Risk management, interface management between drug and device constituents, process validation, cleaning validation, and contamination control strategies. - Manufacturing Transfer & Supplier Oversight
Design transfer, manufacturing transfer, supplier qualification, oversight of critical component manufacturers, and quality agreement development. - Inspection Readiness & Quality Remediation
Inspection readiness, deviation investigations, complaint management, CAPA programs, Data Integrity assessments, and remediation activities. - Training & Organizational Readiness
Training programs for Quality, Manufacturing, Engineering, and Regulatory Affairs teams.